Electra Therapeutics

ETRA
8.8402.96% ( -0.270 )
Closed: Nov 13, 16:00:00 (EDT)

Valuation

Current ValuationThe current P/E ratio is -5.83, within the reasonable range, cheaper than 42.5% of the time in the past 1 years, and the industry ranks 414/607, the industry Median -1.72.

-5.83xP/E
Stock price$8.84Earnings per share$-1.52

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-53.98x162.77%$208.48B
MRNAUSModerna
-31.97x1.49%$89.18B
CSLLYUSCSL Limited
-25.56x--$65.92B
NTRAUSNatera
-280.91x1.38%$46.27B
RVMDUSRevolution Medicines
-19.74x40.80%$36.93B
ROIVUSRoivant Sciences
-83.18x94.91%$28.64B
INSMUSInsmed
-43.89x74.47%$26.58B
BNTXUSBioNTech SE
-12.54x29.49%$21.22B
BBIOUSBridgebio Pharma
-25.76x30.83%$15.25B
SMMTUSSummit Therapeutics
-13.56x23.12%$11.29B
BMRNUSBioMarin Pharma
-579.92x56.09%$11.09B
KYMRUSKymera Therapeutics
-30.36x8.74%$10.61B
PCVXUSVaxcyte
-8.73x42.58%$10.03B
MDGLUSMadrigal Pharma
-63.86x86.93%$9.93B
SYREUSSpyre Therapeutics
-44.09x59.92%$9.88B
PRAXUSPraxis Precision Medicines
-25.52x0.52%$9.17B
RYTMUSRhythm Pharma
-40.21x51.65%$7.97B
ALKSUSAlkermes
-22,515.92x135.31%$7.90B
CYTKUSCytokinetics
-10.05x8.60%$7.82B
TWSTUSTwist Bioscience
-56.43x34.96%$7.35B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.